131 related articles for article (PubMed ID: 34955045)
21. Cutaneous smooth muscle tumors in the dog and cat.
Liu SM; Mikaelian I
Vet Pathol; 2003 Nov; 40(6):685-92. PubMed ID: 14608022
[TBL] [Abstract][Full Text] [Related]
22. P16, Ki67, P53, and WT1 Expression in Uterine Smooth Muscle Tumors: An Adjunct in Confirming the Diagnosis of Malignancy in Ambiguous Cases.
Delgado B; Dreiher J; Braiman D; Meirovitz M; Shaco-Levy R
Int J Gynecol Pathol; 2021 May; 40(3):257-262. PubMed ID: 32897968
[TBL] [Abstract][Full Text] [Related]
23. Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes.
Billings SD; Folpe AL; Weiss SW
Am J Surg Pathol; 2001 Sep; 25(9):1134-42. PubMed ID: 11688572
[TBL] [Abstract][Full Text] [Related]
24. Do GISTs Occur in Rats and Mice? Immunohistochemical Characterization of Gastrointestinal Tumors Diagnosed as Smooth Muscle Tumors in The National Toxicology Program.
Janardhan KS; Venkannagari P; Jensen H; Hoenerhoff MJ; Herbert RA; Malarkey DE; Sills RC; Pandiri AR
Toxicol Pathol; 2019 Jul; 47(5):577-584. PubMed ID: 31064278
[TBL] [Abstract][Full Text] [Related]
25. CD147 expression in uterine smooth muscle tumors, and its potential role as a diagnostic and prognostic marker in patients with leiomyosarcoma.
Ozler A; Evsen MS; Turgut A; Sak ME; Tunc SY; Agacayak E; Alabalik U; Basaranoglu S; Keles AN; Gul T
J Exp Ther Oncol; 2014; 10(4):325-30. PubMed ID: 25509988
[TBL] [Abstract][Full Text] [Related]
26. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.
de Leval L; Waltregny D; Boniver J; Young RH; Castronovo V; Oliva E
Am J Surg Pathol; 2006 Mar; 30(3):319-27. PubMed ID: 16538051
[TBL] [Abstract][Full Text] [Related]
27. Digital Quantification of Ki-67 and PHH3 in the Classification of Uterine Smooth Muscle Tumors.
Cao CD; Rico-Castillo J; De Cotiis D; Richard SD; Rosenblum NG; Chan JSY
Int J Gynecol Pathol; 2021 Nov; 40(6):549-555. PubMed ID: 33323861
[TBL] [Abstract][Full Text] [Related]
28. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.
Martin SA; Sears DL; Sebo TJ; Lohse CM; Cheville JC
Am J Surg Pathol; 2002 Mar; 26(3):292-300. PubMed ID: 11859200
[TBL] [Abstract][Full Text] [Related]
29. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
Amada S; Nakano H; Tsuneyoshi M
Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
[TBL] [Abstract][Full Text] [Related]
30. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
Mittal K; Demopoulos RI
Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
[TBL] [Abstract][Full Text] [Related]
31. Steroid receptors in canine and human female genital tract tumours with smooth muscle differentiation.
Millán Y; Gordon A; de los Monteros AE; Reymundo C; de las Mulas JM
J Comp Pathol; 2007; 136(2-3):197-201. PubMed ID: 17362977
[TBL] [Abstract][Full Text] [Related]
32. Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.
Gökaslan H; Türkeri L; Kavak ZN; Eren F; Sişmanoğlu A; Ilvan S; Durmuşoğlu F
Gynecol Obstet Invest; 2005; 59(1):36-40. PubMed ID: 15377824
[TBL] [Abstract][Full Text] [Related]
33. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
Petrović D; Babić D; Forko JI; Martinac I
Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
35. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: a pathologic analysis of 100 cases.
Ranchod M; Kempson RL
Cancer; 1977 Jan; 39(1):255-62. PubMed ID: 832238
[TBL] [Abstract][Full Text] [Related]
36. h-Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumor.
Watanabe K; Kusakabe T; Hoshi N; Saito A; Suzuki T
Hum Pathol; 1999 Apr; 30(4):392-6. PubMed ID: 10208459
[TBL] [Abstract][Full Text] [Related]
37. The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances.
Clement PB
Int J Gynecol Pathol; 2000 Jan; 19(1):39-55. PubMed ID: 10638452
[TBL] [Abstract][Full Text] [Related]
38. Primary mesenchymal (nonangiomatous/nonlymphomatous) neoplasms occurring in the canine spleen: anatomic classification, immunohistochemistry, and mitotic activity correlated with patient survival.
Spangler WL; Culbertson MR; Kass PH
Vet Pathol; 1994 Jan; 31(1):37-47. PubMed ID: 8140724
[TBL] [Abstract][Full Text] [Related]
39. Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond.
Croce S; Chibon F
Genes Chromosomes Cancer; 2021 Mar; 60(3):129-137. PubMed ID: 33099852
[TBL] [Abstract][Full Text] [Related]
40. Aspiration biopsy cytology of smooth muscle tumors. A cytologic approach to the differentiation between leiomyosarcoma and leiomyoma.
Tao LC; Davidson DD
Acta Cytol; 1993; 37(3):300-8. PubMed ID: 8498132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]